AzTrials
AzTrials

Pressure UlcerPRESDIENCT01834417

Preliminary Study Leading to Prevention of Pressure Ulcers by the Use of an On-board Device : Ergonomic Assessment of Wheelchair-seat Pressures in Spinal Cord Injured (SCI) Patients ( PRESDIE)

A study testing TexiMat in people with Pressure Ulcer, run by Nantes University Hospital at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Analysis of stored seat-pressures in SCI patients during a 4-week use of an on-board device. During this period, patients write in an agenda noteworthy events that could occur while they're using their wheelchair. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pressure Ulcer
What is being tested?
TexiMat
Type of treatment
Medical device
How many people
90 participants
Where
1 siteFrance
Study dates
18 Apr 2013to Jan 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient is male or female, aged ≥ 18
  • Patient accepting the initial assessment and the following visits during the protocol
  • Written informed consent has been obtained
  • Patient having a social assurance
  • Spinal cord injury ≤ C6 stable Spinal cord trauma > 1 an
  • Main mode of ambulation : own manual wheelchair

Who cannot join

  • Aged ≤ 18
  • Adults under guardianship
  • Patients do not speak French, refusing or unable to be followed
  • Pregnant or lactating women
  • Person deprived of their liberty by judicial or administrative decision
  • Person hospitalised without consent
  • Pelvic pressure ulcer ongoing
  • Cognitive disorder incompatible with the use of the device, understanding and conduct of the study

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Nantes

    Nantes, 44093

Other trials in France

About this study

Official title: Preliminary Study Leading to Prevention of Pressure Ulcers by the Use of an On-board Device : Ergonomic Assessment of Wheelchair-seat Pressures in Spinal Cord Injured (SCI) Patients

Analysis of stored seat-pressures in SCI patients during a 4-week use of an on-board device. During this period, patients write in an agenda noteworthy events that could occur while they're using their wheelchair. A control is done every week and the device can be changed until it is returned at the end of the study period.

Read the detailed description
  • inclusion visit : recovery of the signed informed-consent form, clinical examination, skin control, seat-pressures control, device 9-position control, delivery of the agenda for noteworthy events
  • 3 follow-up visits : noteworthy events check, skin control, cushioncloth control, device 9-position control
  • return visit : device return, agenda return, skin control, seat-pressures control
Conditions
Pressure Ulcer
Being tested
TexiMat
Keywords
Pressure ulcer, spinal cord injury, on-board device
Medical subject headings
Pressure Ulcer, Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TexiMatDevice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intra- and inter-patients variability of stored pressures for the whole included population Intra- and inter-patients variability of stored pressures for the whole included population

    Intra- and inter-patients variability of stored pressures for the whole included population Measured at the end of the study

    Each topic will be equipped with a layer of pressure sensors 32x32. The pressure maps are stored every second rule, which will be of the order of 30 000 maps daily. For each topic, we will be able to calculate the frequency and location of peak pressure

    Measured: 4 weeks

Secondary outcomes (1)
  1. Intra- and inter-patients variability of stored pressures for subpopulations

    Intra- and inter-patients variability of stored pressures for subpopulations :

    • quadriplegic vs paraplegic
    • according to high-risk areas for pressure ulcers
    • according to noteworthy events

    Each topic will be equipped with a layer of pressure sensors 32x32. The pressure maps are stored every second rule, which will be of the order of 30 000 maps daily. For each topic, we will be able to calculate the frequency and location of peak pressure Measured at the end of the study

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2013 (estimated)
  2. Study start18 Apr 2013
  3. Primary completionJan 2020
  4. Study completionJan 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01834417
Sponsor's protocol ID
RC11_0009
Acronym
PRESDIE
Status last verified
Feb 2020
First submitted
8 Apr 2013
Last updated
6 Feb 2020
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing TexiMat in people with Pressure Ulcer, run by Nantes University Hospital at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intra- and inter-patients variability of stored pressures for the whole included population Intra- and inter-patients variability of stored pressures for the whole included population (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in